文献速递胸部骨肌技术与安全PETCTMR

PET/CT特征可鉴别新诊断非小细胞肺癌患者中单发骨FDG摄取病灶的转移风险

PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.
PubMed 文献 · Eur Radiol · 2018-10-12

研究纳入118例新诊断非小细胞肺癌伴单发骨FDG病灶且无其他远处转移的患者,分析骨病灶及原发肿瘤的PET/CT特征。骨病灶SUVmax cutoff 4.3诊断转移的敏感度81.8%、特异度84.7%、准确率83.9%,但存在较大重叠;结合骨病灶CT特征与肺肿瘤PET/CT特征可对转移风险进行分层。

要点

  • 骨病灶SUVmax cutoff 4.3诊断转移敏感度81.8%、特异度84.7%、准确率83.9%,但良恶性存在较大重叠。
  • 骨病灶SUVmax≤2、硬化边或骨折者20/20正确诊断为良性;SUVmax>10、软组织肿块或骨破坏者18/18正确诊断为转移。
  • 剩余80例中骨病灶SUVmax>4.3伴溶骨改变及肺肿瘤SUVmax>6.4、≥T2期、≥N1期等特征越多越支持转移。

核心结论

  • 结合骨病灶与肺肿瘤的PET/CT特征有助于对非小细胞肺癌患者单发骨FDG病灶的骨转移风险进行分层。

研究设计与样本

  • 研究纳入118例新诊断非小细胞肺癌患者,均为单发骨FDG病灶且经PET/CT、脑MRI和增强胸部CT证实无其他远处转移;分析骨病灶SUVmax及CT表现、原发肿瘤SUVmax、临床T分期和N分期;骨病灶性质经活检、特征性MRI表现和临床随访判定。

关键影像表现/征象

  • 骨病灶CT表现包括硬化边、骨折、软组织肿块和骨破坏,其中硬化边或骨折见于良性病灶,软组织肿块或骨破坏见于转移病灶。
  • 骨病灶SUVmax≤2、存在硬化边或骨折的20例均正确诊断为良性。
  • 骨病灶SUVmax>10、存在软组织肿块或骨破坏的18例均正确诊断为转移。

诊断标准与关键数值

  • 骨病灶SUVmax cutoff 4.3诊断转移的敏感度81.8%、特异度84.7%、准确率83.9%,但良恶性存在较大重叠。
  • 剩余80例中,骨病灶SUVmax>4.3伴溶骨改变及肺肿瘤SUVmax>6.4、≥T2期(n=70)、≥N1期(n=43)为支持转移的特征。
  • 上述特征中≤1项者38/38正确诊断为良性,≥4项者5/5正确诊断为转移,具有2或3项特征的37例中良性27例、转移10例。

临床应用与阅片要点

  • 单发骨FDG病灶可先测骨病灶SUVmax,≤2且伴硬化边或骨折者倾向良性。
  • 骨病灶SUVmax>10或伴软组织肿块、骨破坏者倾向转移。
  • SUVmax处于中间范围时需结合骨病灶CT特征及肺肿瘤SUVmax、T分期、N分期综合判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We investigated the capacity of fluorodeoxyglucose (FDG) PET/CT features for stratifying probability of metastasis for single-bone FDG lesions in non-small-cell lung cancer (NSCLC).

METHODS: Subjects were 118 newly diagnosed NSCLC patients with a solitary bone FDG lesion and no evidence of other distant metastasis based on PET/CT, brain MRI, and contrast-enhanced chest CT. Bone lesion SUVmax and CT findings, primary tumor SUVmax, clinical T stage, and N stage were analyzed.

RESULTS: The bone lesions were determined by biopsy, characteristic MRI findings and clinical follow-up to be metastatic in 33 (28.0%) and benign in 85 cases (72.0%). A cutoff bone SUVmax of 4.3 showed good diagnostic performance (81.8% sensitivity, 84.7% specificity, and 83.9% accuracy), but there was considerable overlap. Bone lesion PET/CT features of SUVmax ≤ 2, osteosclerotic rim or fracture correctly diagnosed 20/20 benign, while SUVmax > 10, soft-tissue mass or bone destruction correctly diagnosed 18/18 metastatic cases. In the remaining 80 cases, bone features of SUVmax > 4.3 and osteolytic change, and lung tumor features of SUVmax > 6.4, ≥ T2 stage (n = 70), and ≥ N1 stage (n = 43) favored metastasis. The presence of one or less of these features correctly diagnosed 38/38 benign, while the presence of four or more features correctly diagnosed 5/5 metastatic cases. The 37 cases with two or three features had either benign (n = 27) or metastatic bone disease (n = 10).

CONCLUSION: Combining bone lesion and lung tumor PET/CT features can help stratify risk of bone metastasis in these patients.

KEY POINTS: • In NSCLC with a single-bone FDG lesion, lesion SUVmaxis useful for differential diagnosis. • CT features of the single-bone FDG lesions provide additional diagnostic value. • High NSCLC SUVmax, greater T stage, and FDG positive nodes also favor metastasis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lim CH, Ahn TR, Moon SH, et al. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients. Eur Radiol. 2018. PMID: 30315418. doi:10.1007/s00330-018-5764-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。